B. Robert Mozayeni

Dr. Mozayeni is President of ILADS and a board-certified internist in private practice in Bethesda, Maryland where he specializes in the diagnosis and management of chronic inflammatory diseases having rheumatic and neurovascular manifestations. Dr. Mozayeni is a rheumatologist by training with graduate and post-graduate physician-scientist training from Albany Medical College, Yale University, Howard Hughes Medical Institute, and the National Institutes of Health (NCI, NHLBI, and NIAMS). Under an ongoing research collaboration with Dr. Breitschwerdt, Dr. Mozayeni maintains an observational clinical evaluation of the significance of Bartonella infection in a cohort of several hundred human patients with otherwise unexplained chronic conditions. Clinical correlations between Bartonella species and various conditions are being determined as part of ongoing research that continues to redefine diagnostic and therapeutic options as dictated by clinical experience. As founder and Executive Director of the Translational Medicine Group, Dr. Mozayeni helped develop and commercialize software that supports data-driven methods to accelerate the evaluation and improvement of patient-centered care pathways.